MedPath

Effects of early versus delayed enteral nutrition and closed versus open enteral nutrition on high-sensitivity C-Reactive Protein and Tumor Necrosis Factor Alpha in 24 patients admitted in surgery Intensive Care Units

Not Applicable
Conditions
nspecified protein-energy malnutrition.
Protein-energy imbalance NOS
Registration Number
IRCT201403042017N19
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
24
Inclusion Criteria

aged more than 18 years; those who might be stayed in Intensive Care Units for more than 72 hours; Patients with Acute Physiology and Chronic Health Evaluation more than 15-25. Exclusion criteria: aged less than 18 years; patients with hepatic disorders; patients with nephritic syndrome; Hemodinamically unstable; increased lactate in serum; Pregnant women.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum high-sensitivity C-Reactive Protein. Timepoint: In first, third, fifth and seventh days. Method of measurement: Blood sampling.;Serum Tumor Necrosis Factor Alpha. Timepoint: In fiollowing days: first, third, fifth and seventh. Method of measurement: Blood sampling.
Secondary Outcome Measures
NameTimeMethod
Simplified Acute Physiology Score (SAPS II). Timepoint: In following days: first, third, fifth and seventh . Method of measurement: By measuring following parameters: Type of admission? , Chronic diseases, Glasgow , ? Syst. Blood Pressur, ? If MV or CPAP ? PaO2/FIO2(mmHg), ? Urine output, ? WBC,? Potassium,? Sodium,? HCO3,? Bilirubin,? Serum Urea or ? BUN, ? Heart rate,? Temperature.;Sequential Organ Failure Assessment Score (SOFA). Timepoint: In following days: first, third, fifth and seventh. Method of measurement: PaO2/FiO2 (mmHg), Glasgow coma scale, Mean Arterial Pressure, Bilirubin (mg/dl) , Platelets×103/µl, Creatinine (mg/dl).
© Copyright 2025. All Rights Reserved by MedPath